chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body chilling; sweating; sore throat; sense of smell slightly lost; This is a spontaneous report from a contactable consumer (patient).  A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EL9263), via an unspecified route of administration in left arm on 16Feb2021 09:15 AM (at the age of 36-years-old) as a dose 1, single and patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6201), via an unspecified route of administration in left arm on 16Feb2021 (at the age of 36-years-old) as a dose 2, single for COVID-19 immunization. The patients medical history was not reported. The patients concomitant medications (other medications the patient received within 2 weeks of vaccination) included Cephaalosporin, Amoxicillin. The patient had no allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, patient was not been tested for COVID-19. Post vaccination, the patient had underwent lab test which includes Nasal Swab (SARS-CoV-2 test) test resulted as negative on 19Jan2021. On unspecified date patient stated that he experienced Body chilling sweating sore throat lasts for two months, and the sense of smell slightly lost. Patient had not received any treatment for the events reported. The outcome of events was not recovered.  Location of injection information is available for all vaccines received on the same date.
Patient was dizzy at vaccine clinic and was taken to ER as a precaution.  She left the emergency dept before being seen, stating she felt fine.
Initial report received from the patient's parent on 12 November 2008.  A 39-year-old male patient complained of weakness, loss of appetite, night sweats and headaches within 24 hours after receiving a dose of TYPHIN Vi (lot number, route and site of administration not reported). The patient also reported a shift in WBC (white blood cell)count. The patient, who is being sent abroad on 09 December 2008, had previously received a TYPHOID shot eight months ago. Patient outcome was not reported. The patient was scheduled to be evaluated on 12 November and 13 November 2008.
Patient is a 63 year old female with a history of diabetes mellitus, hypertension and migraines.  Patient reports she received the 2nd dose of the Pfizer COVID-19 4 days ago .  Patient reports about 6 hours after the administration she felt achy all over her body.  Patient noticed some bruising/redness over her left lateral or arm soon after the vaccine was administered.   Over the past couple of days she has developed nausea, vomiting and mild lower abdominal cramping.  Patient also has moderate to severe headache affecting her whole head.  Patient had low-grade fever/chills for a couple of days but none since yesterday.  Patient reports no upper respiratory symptoms such as cough, sore throat, runny nose.  She has been taking Tylenol without much relief.  Patient was treated with intravenous fluids and antiemetic medication with improvement in her symptoms
felt cold and chilly; can't move her arm up and down; Fever/ 101.2; body aches; mild pain in arm; This is a spontaneous report from a contactable consumer report self. This 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL4176), via an unspecified route of administration at left arm on 12Jan2021 14:30 at single dose for covid-19 immunization. Medical history included COVID in Nov2020 (Patient was tested for Covid on 23Nov2020 and found out the 25Nov2020 the result was positive), she just quarantined herself at a hotel (They gave her Benzonatate, but she was also taking Tylenol 500mg and Robitussin DM). Concomitant medications not reported. Patient did not get any other shots or 4 weeks prior. No problems with vaccines in past that she can remember. No additional vaccines administered on same date of the Pfizer suspect. Patient received the Pfizer BioNtech vaccine on 12Jan2021 and after that on 12Jan2021 night she didn't feel anything but mild pain in arm, it was so painful, but not as bad on 13Jan2021 even though she still has it. She can't move her arm up and down. On 13Jan2021 morning at dawn she had a fever and it is now 101.2. Has taken Tylenol 500mg (Lot number: SLA071, UPC number: 30047112, Expiry Date: Aug2024). Patient had body aches started 12Jan2021 at midnight (12:00) that is start date of 13Jan2021. She felt cold and chilly and not sure if it was the weather or her. No Emergency Room or Physician Office visit. The outcome of "felt cold and chilly" was unknown, of else events was not recovered.
No adverse events noted. Vaccine was accidentally given 2 weeks prior to recommended dosing of 2 months from previous dose; CDC recommended giving an additional 0.5mL dose of Moderna Bivalent 8 weeks following the previous dose of Moderna Bivalent.
On 10/23/2018, patient came to the pharmacy and complained that she was able to move her left arm but unable to raise her arm higher than her head. She thought that limited movement was due to the injection. I looked at her arm and found no rash or swollen. I recommended her to take some ADVIL and apply some heating pad on her left shoulder. I talked to her on 10/24 and she said she felt a little bit better. I left her a voice mail today 10/25 to follow up.
Swelling under injection arm; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swelling under injection arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling under injection arm). At the time of the report, SWELLING (Swelling under injection arm) had not resolved.            Concomitant product use was not provided by the reporter.  Patient had swelling under her injection arm about two weeks after her first dose.The swelling went down just a little before receiving her second dose on 14 May2021. Patient still had swelling under her same arm of injection.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-218715 (Patient Link).   Reporter did not allow further contact
This spontaneous case was initially received on 17-NOV-2015. The case report was received from a(n) Health Professional and concerns a(n) elderly male patient in his seventies. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/event(s): The patient received an unspecified flu vaccine on unknown dates, batch no: not provided, Route of administration: Unknown, Dose: no information provided. Additional suspect drug(s): PNEUMOVAX23, batch no: Unknown. Reaction(s)/event(s) and outcome: On an unknown date after starting/treatment with an unspecified flu vaccine, the patient experienced Redness at the injection site (non serious, outcome: Unknown) and Swelling at the injection site (non serious, outcome: Unknown). The events occurred 6 days after receiving PNEUMOVAX23. The patient received the unspecified flu vaccine "within the last few weeks". Reporter's assessment: Not reported.
Flu-like symptoms, swelling at shot location, and not sure if related but on July 29th, mucus plug was lost and on August 1st, membrane ruptured at 29 weeks, 4 days pregnant in an otherwise very uneventful pregnancy. At 3 weeks after shot was administered, there is still a lump under the tissue of my arm approximately the size of a grape. Have been on bedrest at the hospital since August 1st. This is an unusual situation as the TDAP is recommended for pregnant women and not sure if there was an allergic reaction or if it triggered an immune response that caused water to break.
I was not on my period and no vaginal break through bleeding was occurring. I experienced blood in my urine three times that day (3/11/21). I sought treatment at urgent care and they found nothing in my urine screen. The doctor advised me it was likely a reaction to my vaccine so I am reporting for follow up.
"fever 101, severe headache, myalgias, symptoms resolved over 36 hours"
Patient reports feeling dizzy, and  faints. He is immediately evaluated by medical emergency personnel who proceeds to elevate lower extremities. Vital signs are monitor: BP 110/60 P 53 Sat% 99 dxt 136mg/dl. Patient regains consciousness and is placed on a stretcher. Doctor is notified by phone. Observed patient for thirty minutes to reassess BP 120/60 Sat 99 P 78
At this time patient has remained free of any s/sx of adverse reaction, reporting that he received the wrong dose of vaccine, on 5/4/2021 he was to receive 0.5ml of Jensen Covid vaccine and he received 2.5ml of the vaccine.
First dose made me really sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   The reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient had the first dose of Shingles vaccine and it made the patient really sick. For tolerance to the 2nd dose of Shingrix, refer case US2021AMR041513.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR041513:Same reporter.
Changes to menstrual cycle. Due around March 10 and started 2 weeks late, heavier than normal, unusual breast tenderness. Actually was researching ?recanalization? of husband?s vasectomy in May 2020 thinking I could be pregnant prior to starting menstruation. Just read an article that some women are reporting menstrual changes after getting vaccinated and I did for sure but never thought it could be related.
pt who has a resp disorder recvd flu vax & serum theophylline level became elevated & exp a sz for which was hospitalized;
Continuous complaints of arm pain, difficulty moving arm due to pain, worsened on 3rd day, red area noted on 4th day red area large, raised area approximately 1-1.5 mm, approximatly 3-4 inch diameter round
Pt (DOB 10/21/1978) received first dose of Pfizer COVID vaccine with lot number EP7534 expiration date 03/17/2021 at 1010. At 1033 client reported dizziness to RN. EMTs brought client to zero gravity chair at EMT station. Client reported having eaten last at 0940, about thirty minutes prior. Vital signs at 1037: BP of 116/84, pulse of 62 BPM, and 22 respirations per minute. At 1039 water was provided to client and client then disclosed feeling better lying down. No signs or symptoms of allergic reaction were noted. At 1042 vitals: BP of 118/82 and pulse of 60 BPM, and 22 respirations per minute. At 1047 vital signs: BP of 106/82, pulse of 63 BPM, and 20 respirations per minute. At 1054 vital signs: BP of 110/80, pulse of 66 BPM, and respiratory rate of 22 per minute. Client declined EMS when offered. At 1103 client stated, "it feels much better", requesting to leave. Client then left the site with stable gait, alert and oriented x3, driving herself.
Pt recv vax on 11/5/98; on 11/6/98 pt exp pain in LA, nausea x 5 day; 11/13/98 pt exp pain/swelling at LA vax site
5-7 days after receiving vaccine, patient presented w/ red spots/rash all over body. Patient treated by dermatologist since 12/2012 and was referred to us today to check with manufacturer. This was first time adverse reaction brought to our attention.
This patient stopped in and requested a high dose influenza vaccine. Paperwork was processed and he was given the vaccination. Afterwards while entering the vaccine into system we discovered that the patient had previously received the same vaccination on 10/15/2021 at another local pharmacy. I called the patient to verify that this information was correct. He stated that it was and he didn't intend to get two, but rather forgot that he had already received one this year. I asked him how he was feeling and at that time he reported that he was not having any adverse events. This was approximately 4 hours after his injection on 12/2/21. We told him to contact us at any point if he was not feeling well, but so far he has not called back.
administration of expired moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vaccines were stored in freezer and one to two vials were taken out and placed in fridge each day as needed. No concomitant medications were reported. No treatment medications were reported.
Lactation (prolactin hormonal imbalance) Skin Acne, Period Irregular still ongoing as of (07/22/2021).
Vaccines given on 6/22/05 and mother called on 6/23/05 reporting patient's left upper arm in the deltoid area was very red, swollen and hard.  Instructed mom to use cold compresses and tylenol or Motrin for pain.  Called mother on 6/24/2005 and mom reported arm had gotten worse on the 23rd and was now swollen from the top of the shoulder down to the elbow and was hard in the whole area.  She said it did not seem to be getting any worse that day.  Parent called on 6/29 to follow up and mom reported that it was still swollen and painful until 6/27 but now all remains is a egg size hard area around the injection site.
She is high risk but she had a stroke within a couple of weeks of the Moderna vaccine. There's no way to know if it is related but definitely something that needs to be tracked.
pt recv vax & devel an allergic rxn characterized by gen urticaria, swelling of the tongue & lips, fever, wheezing & diarrhea;pt recv unspecified med @ vaccinating ped office & recovered;
Felt crummy on day one and two better on day three and on day four developed four blood clots on Coumadin with an INR of 4.5 and died the next day on 3/31/2021.
Patient was nervous prior to vaccination. Immediately after receiving vaccine reported dizziness and nausea. Patient was sat down in a separate room and monitored by team member.
Presented with Health Dept today, 7-24-09 at 10:30 am, with very red, raised, swollen, hot and tender area approx 13cm in diameter, around VZV injection site- upper RT arm. Denied respiratory problems sent to PCP for eval since child with need medical exemption or titers to VZV#2 will not be given.
On day 5, severe nausea and repeated vomiting, lots of bile, became super hot, then freezing cold, shaking. Had to leave work. Flu like symptoms with really bad vomiting. At home resting. Might go to hospital.
Patient received Moderna dose 3 but had requested Pfizer dose 3 on immunization paperwork
Within 5 minutes of shots - started sl cough, then within 30 minutes red from head to toe & itchy all over. Given oral BENADRYL.
This case was reported by a pharmacist via call center representative and described the occurrence of chills in a 66-year-old female patient who received SHINGRIX (batch number ZY3X4, expiry date 28th April 2020). On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced chills. On an unknown date, the outcome of the chills was unknown. It was unknown if the reporter considered the chills to be related to SHINGRIX. Additional information was received as follows: The health care professional reported that the patient experienced chills or shivering after receiving SHINGRIX. This case has been linked with case US2018047707, reported by the same reporter.
Information has been received from a Medical Assistant concerning a patient who on 28-JUL-2010 was inadvertently vaccinated with VARIVAX (Merck) instead of ZOSTAVAX (Merck). No adverse effect reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
Client received the 1st dose of the COVID vaccine (Moderna Lot # 027C21A expiration 07/01/2021) at 1534. At 1546 client walked up to the front of the observation room and was reading the EMT sign with the list of allergic reaction symptoms. EMT asked her if she was feeling okay. She stated, "I'm feeling a weird feeling in the back of my throat." PHN responded at 1547. Client stated that it "felt like a tightness, and I'm having a little difficulty swallowing." Client denied shortness of breath, difficulty breathing, or swelling. PHN administered 50 mg of PO Benadryl to the client at 1551. Vital signs were taken at 1552 (blood pressure 122/80, heart rate 91, oxygen 98%). Client was alert and oriented times four. Skin color was appropriate to race. At 1559, client stated that the "feeling is a little better." Vital signs taken at 1601 (blood pressure 126/82, heart rate 79, oxygen 95%). At 1601 client stated that, "the tightness is almost gone." Vital signs taken at 1616 (blood pressure 120/82, heart rate 86, oxygen 98%). The client has a medical history of autoimmune disease and takes Plaquenil and folic acid. The client is allergic to shellfish. PHN advised the client to follow up with her primary care provider and to consult with an allergist before receiving her second dose of the COVID vaccine. PHN also provided education on when to seek emergency services. At 1617, client stated, "I don't feel the tightness anymore. I feel fine now," and left the facility unassisted with a steady gait. Client stated that she had a ride and was not driving herself home.
Family from another area, new to city, mom is a nurse, called several days after immunization to report: client experienced high fever, brownish rash on various parts of body.
7-29 bilateral facial paresthesia (numb face from cheeks down and heaviness in cheeks).  Contacted urgent care. PA prescribed prednisone.  7-30 some numbness in arms. 7-31 facial paresthesia has subsided some but still present.  Numbness and heaviness in arms causing discomfort and some numbness in legs and feet. 8-1  and 8-2 numbness in face, arms and legs.
The patient had a severe reaction to his first SHINGRIX vaccination on 1/5/19. His arm was so sore and inflamed at the injection site that he could barely move it for 2-3 days after the shot. He had fever and chills for a few days. On day 2 he developed a painful shingles-like rash on his stomach. By day 3 or 4 the rash had become a full body rash. The patient had to go to urgent care to receive a MEDROL shot and also an Rx for a MEDROL Dose Pack. Patient missed 1 whole week of work as a teacher as a result of his adverse reaction to SHINGRIX.
DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
"Pfizer-Bio-Tech COVID-19 Vaccine EUA" Individual received second vaccine on the 15 th day after the 1 st dose. She stated that was the return appointment that was given to return
This spontaneous report as received from a physician refers to 3 unspecified patients of unknown age and gender. On an unspecified dates since 21-FEB-2015, the patients were vaccinated with a dose of an improperly stored ROTATEQ (route oral, lot # K011663, expiration date 24-APR-2016, dose not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a consumer refers to a 2 year old female patient. The reporter "had heard" that an unspecified 2 years old female patient experienced febrile seizures after receiving M-M-R II "within the past year" in 2012. No date, lot# or administration information was provided. Upon internal review, febrile seizures was determined to be medically significant event. This is one of two reports received from the same reporter. Additional information has been requested.
This is a spontaneous report from a contactable consumer. This consumer reported similar events for 15 patients. This is 9th of 15 reports. A patient of unspecified age ethnicity and gender received PREVNAR 13 via an unspecified route of administration at single dose on an unspecified date for immunisation. The patient's medical history and concomitant medications were not reported. Pneumococcal 13-val conj vac (dipht crm197 protein) was exposed to 11 degrees Celsius for eight days. On an unspecified date the patient received pneumococcal 13-val conj vac (dipht crm197 protein) after temperature excursion. Pneumococcal 13-val conj vac (dipht crm197 protein) Lot#, Expiration date# and NDC# was provided (Lot# Q02071, Expiration date# Jan2018, NDC# 0005197101), however it was not confirmed if all patients were administered with the same Lot# or not. Sender's Comments: Linked Report(s): US-PFIZER INC-2016548681 Same drug/event, different patient.
This spontaneous report was received from a nurse practitioner, concerning to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 29-APR-2014 the patient received the first dose of PNEUMOVAX23 (dose, dose number, lot number, expiration date and route were not reported). On 23-OCT-2014, the patient was vaccinated with the second does PNEUMOVAX23 (dose, dose number, lot number, expiration date and route were not reported). No adverse symptoms reported. Co-suspect and concomitant therapies were not reported. Additional information has been requested.
3 weeks after Tdap vaccine, awakened with painful, hands and feet, malaise, fatigue. Initially would occur as frequent episodes. Pain was symetrical occuring in hands feet, arms. Now have several episodes per week when I am unable to use extremity involved until it runs it's course of hours to days. I am now being treated for palindromic rheumatism with humira and methyltrexate so far without results. I had a previous diptheria/tetanus vaccine  in 1974 with swelling of upper arm and malaise. treated with benedryl and resolved. In 1978 contacted hepatitis B from a needle stick. Had severe arthralgias and myalgias until becoming jaundiced when they dissappeared for a few weeks and then returned lasting episodically for several years (about 6)always assoc with general feeling of being unwell.